Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Peter Mazal"'
Autor:
Wolfgang Raber, Raphael Schendl, Melisa Arikan, Andreas Scheuba, Peter Mazal, Valerie Stadlmann, Reinhard Lehner, Petra Zeitlhofer, Sabina Baumgartner-Parzer, Cornelia Gabler, Harald Esterbauer
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
PurposeThe natural history in unselected cohorts of patients with pheochromocytoma/ paraganglioma (PPGL) followed for a period >10 years remains limited. We aimed to describe baseline characteristics and outcome of a large cohort and to identify pred
Externí odkaz:
https://doaj.org/article/f1c7723d30c942caa71cf20c81027639
Autor:
Philipp Melhorn, Peter Mazal, Ladislaia Wolff, Elisabeth Kretschmer-Chott, Markus Raderer, Barbara Kiesewetter
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Somatostatin analogs (SSA), specifically octreotide and lanreotide, have demonstrated antiproliferative effects in patients with neuroendocrine tumors (NET), a group of rare malignancies of diverse origin and presentation. A prominent feature of NET
Externí odkaz:
https://doaj.org/article/a945e9c944a04e59890b3ab8653e808d
Autor:
Philipp Melhorn, Elisabeth Kretschmer-Chott, Ladislaia Wolff, Alexander Haug, Peter Mazal, Markus Raderer, Barbara Kiesewetter
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Different oncological therapies have been approved for small intestinal neuroendocrine tumors (SI-NETs), but relatively little is known about efficacy and long-term outcome outside of phase III trials. Methods: This retrospective analysis
Externí odkaz:
https://doaj.org/article/091def839d3d4f219287fa4f35e93bb9
Autor:
Judith Stangl-Kremser, Sazan Rasul, Jeffrey J. Tosoian, Simpa S. Salami, Alexander Zaslavsky, Aaron Udager, Peter Mazal, Renate Kain, Eva Comperat, Marcus Hacker, Alexander Haug, Markus Mitterhauser, Carmen Pozo-Salido, Christina Steinbach, Melanie R. Hassler, Gero Kramer, Shahrokh F. Shariat, Ganesh S. Palapattu
Publikováno v:
European Urology Open Science, Vol 30, Iss , Pp 63-66 (2021)
Initial reports of a clinical response in patients treated with the radioligand [177Lu]-PSMA-617 for castration-resistant prostate cancer (CRPC) are promising, despite known inter- and intrapatient heterogeneity. In metastatic CRPC, we examined the a
Externí odkaz:
https://doaj.org/article/a2b9edb485a247728f43555379aaa0bd
Autor:
Barbara Kiesewetter, Philipp Riss, Christian Scheuba, Peter Mazal, Elisabeth Kretschmer-Chott, Alexander Haug, Markus Raderer
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Adrenocortical carcinoma (ACC) is a rare malignancy characterized by aggressive biology and potential endocrine activity. Surgery can offer cure for localized disease but more than half of patients relapse and primary unresectable or metastasized dis
Externí odkaz:
https://doaj.org/article/27d6c627182048428b58b5b98df8abf9
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Acute kidney injury represents a major threat to the transplanted kidney. Nevertheless, these kidneys have the potential to fully recover. Tubular regeneration following acute kidney injury is driven by the regenerative potential
Externí odkaz:
https://doaj.org/article/ddba21240dd448e89bb9f0fc7f576309
4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Autor:
Lucian Beer, Stephan H Polanec, Pascal A T Baltzer, Georg Schatzl, Dietmar Georg, Christian Schestak, Anja Dutschke, Harald Herrmann, Peter Mazal, Alexander K Brendel, Shahrokh F Shariat, Helmut Ringl, Thomas H Helbich, Paul Apfaltrer
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0225673 (2019)
PurposeAdvanced forms of prostate cancer (PCa) radiotherapy with either external beam therapy or brachytherapy delivery techniques aim for a focal boost and thus require accurate lesion localization and lesion segmentation for subsequent treatment pl
Externí odkaz:
https://doaj.org/article/97a6c65301e849c0a264cf1f32cb221e
Autor:
Cédric Nesti, Konstantin Bräutigam, Marta Benavent, Laura Bernal, Hessa Boharoon, Johan Botling, Antonin Bouroumeau, Iva Brcic, Maximilian Brunner, Guillaume Cadiot, Maria Camara, Emanuel Christ, Thomas Clerici, Ashley K Clift, Hamish Clouston, Lorenzo Cobianchi, Jarosław B Ćwikła, Kosmas Daskalakis, Andrea Frilling, Rocio Garcia-Carbonero, Simona Grozinsky-Glasberg, Jorge Hernando, Valérie Hervieu, Johannes Hofland, Pernille Holmager, Frediano Inzani, Henning Jann, Paula Jimenez-Fonseca, Enes Kaçmaz, Daniel Kaemmerer, Gregory Kaltsas, Branislav Klimacek, Ulrich Knigge, Agnieszka Kolasińska-Ćwikła, Walter Kolb, Beata Kos-Kudła, Catarina Alisa Kunze, Stefania Landolfi, Stefano La Rosa, Carlos López López, Kerstin Lorenz, Maurice Matter, Peter Mazal, Claudia Mestre-Alagarda, Patricia Morales del Burgo, Els J M Nieveen van Dijkum, Kira Oleinikov, Lorenzo A Orci, Francesco Panzuto, Marianne Pavel, Marine Perrier, Henrik Mikael Reims, Guido Rindi, Anja Rinke, Maria Rinzivillo, Xavier Sagaert, Ilker Satiroglu, Andreas Selberherr, Alexander R Siebenhüner, Margot E T Tesselaar, Michael J Thalhammer, Espen Thiis-Evensen, Christos Toumpanakis, Timon Vandamme, José G van den Berg, Alessandro Vanoli, Marie-Louise F van Velthuysen, Chris Verslype, Stephan A Vorburger, Alessandro Lugli, John Ramage, Marcel Zwahlen, Aurel Perren, Reto M Kaderli
Publikováno v:
The Lancet Oncology, 24(2), 187-194. Lancet Publishing Group
The lancet oncology
The lancet oncology
BACKGROUND Awareness of the potential global overtreatment of patients with appendiceal neuroendocrine tumours (NETs) of 1-2 cm in size by performing oncological resections is increasing, but the rarity of this tumour has impeded clear recommendation
Autor:
Markus Hartenbach, Marcus Hacker, Shahrokh F. Shariat, Lukas Kenner, Peter Mazal, Martin Susani, Gero Kramer, Christian Seitz, John Babich, Marko Grahovac, Neydher Berroteran-Infante, Theresa Balber, Markus Mitterhauser, Sarah Pfaff, Wolfgang Wadsak, Gregor M. Goldner, Alexander R. Haug, Thomas H. Helbich, David D’Andrea, Sabrina Hartenbach, Pascal Baltzer, Bernhard Grubmüller
Purpose:Primary staging of prostate cancer relies on modalities, which are limited. We evaluate simultaneous [68Ga]Ga-PSMA-11 PET (PSMA-PET)/MRI as a new diagnostic method for primary tumor–node–metastasis staging compared with histology and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b642cdf62410bf21b5fec114d205277
https://doi.org/10.1158/1078-0432.c.6527199.v1
https://doi.org/10.1158/1078-0432.c.6527199.v1
Autor:
Markus Hartenbach, Marcus Hacker, Shahrokh F. Shariat, Lukas Kenner, Peter Mazal, Martin Susani, Gero Kramer, Christian Seitz, John Babich, Marko Grahovac, Neydher Berroteran-Infante, Theresa Balber, Markus Mitterhauser, Sarah Pfaff, Wolfgang Wadsak, Gregor M. Goldner, Alexander R. Haug, Thomas H. Helbich, David D’Andrea, Sabrina Hartenbach, Pascal Baltzer, Bernhard Grubmüller
Supplemental methods and results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322e653fb974210b279feb57e470c836
https://doi.org/10.1158/1078-0432.22469289
https://doi.org/10.1158/1078-0432.22469289